Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg
Abstract Background Atrial fibrillation is a growing epidemic in Africa. Anticoagulation, considered the backbone for non-valvular atrial fibrillation (NVAF) management, is limited to warfarin as the mainstay of available anticoagulation therapy in most low- and middle-income countries (LMIC). The o...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2024-10-01
|
| Saila: | Thrombosis Journal |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12959-024-00663-y |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
